Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck

Area of Science:

• Endocrinology
• Oncology
• Radiation Oncology

Background:

• Head and neck radiotherapy can encompass the hypothalamus and anterior pituitary gland.
• Assessing long-term endocrine function after treatment is vital.

Observation:

• 110 patients treated for nasopharyngeal and paranasal sinus cancers were studied 1-26 years post-radiotherapy.
• Hypothalamus and anterior pituitary doses ranged from 400-7500 rad (median 5000-5618 rad).
• Thyroid radiation doses ranged from 3000-8800 rad (median 5000 rad).

Findings:

• Endocrine deficiencies were observed in 91% of patients.
• Hypothalamic lesions occurred in 76 patients; primary pituitary deficiency in 43.
• Hypothyroidism was noted in 40% of patients receiving neck radiotherapy.

Implications:

• Radiotherapy for head and neck tumors commonly leads to endocrine dysfunction.
• Early screening and intervention for endocrine deficiencies are recommended.
• Long-term follow-up is essential as complications may manifest late.